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ABSTRACT
Background: Alzheimer’s disease (AD) is a neurodegenerative disorder with progressive loss of cognitive 
abilities and memory loss. The aim of this study was to compare neuropathological changes in 
hippocampus and brain cortex in a rat model of AD. Methods: Adult male Albino Wistar rats (weighing 
250-300 g) were used for behavioral and histopathological studies. The rats were randomly assigned to three 
groups: control, sham and β-amyloid (Aβ) injection. For behavioral analysis, Y-maze and shuttle box were 
used, respectively at 14 and 16 days post-lesion. For histological studies, Nissl, modified Bielschowsky and 
modified Congo red staining were performed. The lesion was induced by injection of 4 µL of Aβ (1-40) into 
the hippocampal fissure. Results: In the present study, Aβ (1-40) injection into hippocampus could decrease 
the behavioral indexes and the number of CA1 neurons in hippocampus. Aβ injection CA1 caused Aβ 
deposition in the hippocampus and less than in cortex. We observed the loss of neurons in the hippocampus 
and cerebral cortex and certain subcortical regions. Y-maze test and single-trial passive avoidance test showed 
reduced memory retention in AD group. Conclusion: We found a significant decreased acquisition of passive 
avoidance and alternation behavior responses in AD group compared to control and sham group (P<0.0001). 
Compacted amyloid cores were present in the cerebral cortex, hippocampus and white matter, whereas, 
scattered amyloid cores were seen in cortex and hippocampus of AD group. Also, reduced neuronal density 
was indicated in AD group.  Iran. Biomed. J.  15 (1 & 2): 51-58, 2011
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INTRODUCTION
lzheimer's disease (AD) is a complex, 
chronic and devastating disease affecting a 
high percentage of the population over 65
years of age [1]. Oxidative stress may underlie the 
progressive neurodegeneration characteristic of AD
[2]. The neurodegenerative process in AD may 
involve β-amyloid (Aβ) toxicity. Neurotoxicity of 
Aβ can be demonstrated in vitro, and appears to 
involve oxidative stress [3]. Aging, the major risk 
factor for AD [4], leads to loss of free radical 
scavenging ability by endogenous mechanisms [5]. 
Free radical-mediated damage to neuronal 
membrane components also is implicated in aging, 
as well as the etiology of AD [6]. Most cases occur 
sporadically, although a small proportion is inherited 
as an autosomal dominant disorder. Several gene 
loci are involved in familial cases, including the 
amyloid precursor protein gene on chromosome 21, 
the presenilin-1 gene on chromosome 14 and the 
presenilin-2 gene on chromosome 1. There is an 
increased incidence of sporadic Alzheimer's disease 
in individuals with ApoE e4 genotype on 
chromosome 19. Females are affected almost twice 
as frequently as males [7]. 
AD is associated with cholinergic neuronal loss [8] 
and characterized by deficits in memory and 
A
D
ow
nl
oa
de
d 
fro
m
 ib
j.p
as
teu
r.a
c.i
r a
t 1
3:1
0 I
RS
T o
n S
atu
rda
y D
ec
em
be
r 1
5th
 20
18
    
    
  [ 
DO
I: -
 ]  
52                                                                                              Nobakht et al.                                Iran. Biomed. J., January & April 2011
http://IBJ.pasteur.ac.ir
cognition that are associated with significant losses 
of presynaptic cholinergic function in the brain, 
particularly the nucleus basalis [9, 10]. The major 
microscopic abnormalities of AD, which form 
the basis of the histologic diagnosis, are neuritic 
plaques and neuro-fibrillary tangles. There is 
progressive and eventually severe neuronal loss 
and reactive gliosis in the same regions that bear 
the burden of plaques and tangles. Neuritic 
plaques are focal, spherical collections of 
dilated, tortuous, neuritic processes often around 
a central amyloid core, which may be 
surrounded by clear halo [11]. 
Aß has been shown to provoke neuronal death, 
decreased synaptic plasticity, aberrant sprouting of 
growing axons, chronic inflammation and 
hyperphosphorylation of tau [12]. Deposition of Aβ 
is an early and critical event in the pathogenesis of 
AD [13], first forming in temporal cortical regions 
including the hippocampus [14], a region implicated 
in memory formation [15]. It was proposed that Aβ 
aggregates to form neurotoxic plaques, which lead to 
neurodegeneration accompanied by dementia. The 
present experiment was to evaluate the effects of 
injection of Aβ intrahippocampal on memory tasks 
in adult male rats measured by behavioral tests (Y-
maze and passive avoidance) and histopathological 
examination. Inhibitory avoidance (also called 
passive avoidance) is acquired in only one trial, 
where the subject is punished for doing something 
such as entering a new compartment (test) [16]. Cell
death can occur by two morphologically and 
biochemically distinct pathways: necrosis and 
apoptosis. These two pathways are not mutually 
exclusive, and both types of death have been
observed in the brain in AD. 
Apoptotic cells show morphological changes that 
include condensation and fragmentation of 
heterochromatin, membrane blebbing, loss of the 
nuclear envelope, and cellular fragmentation into 
apoptotic bodies, whereas most of the organelles
remain intact [17]. Similarly, small arterioles, 
venules, and capillaries within cerebral cortex also 
frequently bear amyloid deposits [18]. In the present 
study, we have shown comparative neuropatho-
logical changes between hippocampus and brain 
cortex after Aβ bilateral injection into each 
hippocampus in CA1. 
MATERIALS AND METHODS
  Animals. Thirty adult male Albino Wistar rats 
(weighing 250-300 g, 8-10 weeks old), obtained 
from the Animal Center of Iran Medical College, 
were used in this experiment. The rats were 
randomly assigned to three groups with ten animals 
in each group: A) Control group age-matched rat, 
B) Sham-lesioned group, injected with deionized 
water and C) Experimental-lesioned group, injected 
with Aβ (1-40). All animal procedures were 
performed in accordance with the Guide to the 
Iranian Council for Use and Care of Animals and 
were approved by the Animal Research Ethical 
Committee of Tehran University of Medical ciences.
  Animal surgery. Synthetic Aβ-40 amyloid protein 
(Sigma, CA, USA) was dissolved in deionized water 
at a concentration of 2 nmol/μl and then aliquot and 
stored at -70°C before use. Rats were anesthetized 
with intraperitoneal injection of ketamine and 
xylazine (60 and 20 mg/kg body weight, 
respectively, Alfasan, Woerden, Holland). Animals 
were placed in the stereotaxic frames (Stoelting Co. 
USA), the skull exposed and disinfected with 
betadine. An incision was made into the scalp and 
the cranium drilled to a depth of 2.6 mm. The place 
was localized at 2.0 mm medial-lateral and 3.8 mm 
posterior-anterior to bregma, following by Paxinous 
and Watson atlas (1986). In AD group, 4 µl solution
of Aβ40 amyloid protein was bilaterally injected into 
each hippocampus with a 10 µl Hamilton syringe 
over a period of 12 min. The infusion was made over 
10 minutes, retained 2 minutes, and retarded 2
minutes to allow for complete diffusion of drug [1].
The needle was slowly withdrawn after injection. 
Sham group underwent the same procedures except 
that only deionized water was injected.
  Y-maze task. Y-maze test was initiated 14 day after 
Aβ injection. All testing was carried out from 3 p.m.
to 6 p.m. The Y-maze was a Y-shaped plexiglas 
holding cage with a 40 cm length, 30 cm height and 
15 cm width. Rats were allowed to freely discover 
the maze for 8 min observation period. Air 
circulation equipment in continuous operation 
provided masking noise of 40 dB. Alternation was 
defined as successive entries into the three arms on 
overlapping triplet sets. The alternation percentage 
was calculated as the ratio of actual to possible 
alternations (defined as the total number of arm 
entries minus two) [19].
  Single-trial passive avoidance test. This test was 
performed 16 days after surgery. The apparatus 
(Behin Paya Tajhiz Co., Tehran) consisted of light 
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and dark compartments of equal size connected by a 
small central guillotine door. Electric shocks were 
given to the rats in the dark compartment with the 
grid floor. All rats were adapted to the apparatus on 
the first and second days of testing for 5 min. On the 
third day, the rats individually entered the light 
compartment and remained there for 2 min, then the 
guillotine door was opened and the rat entered the 
dark compartment and received a 2 s, 1 mA electric 
footshock. For retention, 24 hours later, each rat was 
again placed in the light compartment. The latency 
to step through the dark compartment (maximum 
600 s) was measured and recorded as the index for 
the passive avoidance behavior. The behavioral 
observations were carried out between 12:00 and 
15:00 [19].
  Histological procedure. After the behavioral test, 
animals were killed 12 weeks after surgery and 
brains were removed and dissected into hippocampal 
and cortex blocks. After the behavioral test, all rats 
were anesthetized with ketamine and xylazine and 
perfused with 4% paraformaldehyde in 0.1 mol/L 
phosphate buffer solution (pH 7.4). Then, the brains 
were removed and fixed in the similar solution for 
24 h. Following routine processing in paraffin, serial 
coronal sections of the brain were cut at 8 µm 
thickness in a rotary microtome (Leitz, 1512, 
Germany). The parts of each rat brain section were 
stained with modified Bielschowsky, Nissl staining, 
and modified Congo red staining. Modified 
Bielschowsky gives a good compromise between 
sensitivity for plaques and tanges can be used as a 
single stain for diagnosis of AD. Briefly, sections 
were deparaffinized through xylene and alcohols 
into tap water before being placed into fresh 20%
silver nitrate solution for 20 min. After washing 
thoroughly with distilled water, slides were 
immersed in 20% silver nitrate solution titrated with 
fresh sodium hydroxide and evaporated ammonia 
(200 ml of 28% ammonium hydroxide by leaving in 
an open beaker for 20 min in a fume cupboard). 
After 15 min, slides were washed with ammonia 
water before being individually developed with 100
ml of developer (20 ml of formaldehyde, 100 ml 
distilled water, 20 µl concentrated nitric acid, and 
0.5 g citric acid) and then added to 50 ml of titrated 
silver nitrate solution. Slides were then rinsed in tap 
water, fixed in 5% sodium thiosulfate, and de-
hydrated through alcohols and xylene. Congo red 
staining is an accepted histochemical marker for the 
β-pleated-sheet structure of amyloid. Sections were
deparaffinized through xylene and alcohols into tap 
water. Afterwards, slides were immersed in alkaline 
sodium chloride. After 20 min, they were immersed 
in alkaline Congo red solution for 20 min and then 
differentiated with alcoholic potassium. After this, 
slides were counterstained with alum hematoxylin 
and dehydrated through alcohols and xylene. All of 
the cerebral cortex and molecular layer cells in the 
CA1 region were counted on Nissl stained under a 
light microscope at 40× magnification. Four 
contiguous 0.936 mm2 areas in cortex and 0.26 mm2
areas in hippocampus were counted. Measurement 
of the area was performed using the Olysia 
BioReport software imaging system (Olympus 
Corporation, Tokyo, Japan) [20] and neuritic
plaques were counted on modified Bielschowsky 
stained separately in cortical regions and 
hippocampus at 100× magnification.
  TUNEL procedures. Terminal deoxynucleotidyl 
transferase (TdT)-mediated dUTP nick-end labeling 
(TUNEL) staining for apoptotic neurons was 
performed according to the manufacturer's 
instruction [21]. Cell death was detected in situ in 
resected tissues by enzymatic labeling of DNA 
strand breaks using a TUNEL assay according to the 
manufacturer’s instructions. Paraffin-embedded 
tissue were deparaffinized in xylene and rehydrated 
with ethanol series (absolute, 95%, 90%, 80%, 70%, 
diluted in double distilled water). After this stage 
and all subsequent stages, washing with PBS was 
performed. The sections were treated with proteinase 
K (20 μg/ml in 10 mM Tris/HCl, pH 7.6) for 30
minutes, the endogenous peroxidase activity was 
blocked by using 0.3% H2O2 in methanol for 30
minutes. Then, the sections were prepared with 
permeabilization solution (0.1% Triton X-100, 0.1%
sodium citrate) for 15 minutes. The labeling of 
apoptosis was induced by TdT, which catalyses 
deoxyribonucleotide, and fluorescein conjugated 
dUTP. During this step, slides were coverslipped 
and incubated in a humidity chamber at 37°C for 60
minutes. Then, the sections were washed and 
incubated with a convertor-POD at 37°C in a  
humidity chamber for 30 minutes. After a wash, 
color was developed by incubating sections with a 
diaminobenzidine substrate solution for 15 minutes. 
After a final wash, sections were viewed by light 
microscopy and only those cells with positive 
TUNEL staining and of apoptotic morphology were 
considered apoptotic [22].
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Fig. 1. Percent of alternation behavior in Y-maze task in 
studied groups (mean ± SEM). *P<0.0001 as compared to sham
and control groups. 
  Statistical analysis. All results were performed as 
mean  S.E.M. for the behavioral tests including
passive avoidance test and Y-maze task and 
Neuronal counts in cerebral cortex and CA1, one-
way analysis of variance (ANOVA) was used.
Normality and homogeneity of the data were 
confirmed before ANOVA analysis. In all analyses, 
a P value of <0.05 was considered statistically 
significant.
RESULTS
Y-maze task. For Y-maze task, short-term spatial 
memory performance was examined in this study. 
The mean scores of alternation behavior for sham, 
control, and AD group were 80.56, 86.7, and 46.2%,
respectively. AD group showed a significant 
reduction in alternation behavior as compared to
control and sham group (P<0.0001, Fig. 1). There
Fig 2. Single-trial passive avoidance test. Initial latency of 
control and sham rats compared to AD group, *P<0.0001.
was no significant difference between sham and 
control groups. 
  Single-trial passive avoidance test. The 
performance of control and AD group rats for 
passive avoidance test was shown by initial and 
step-through latency. The AD group rats indicated 
significant damage in retention in passive avoidance 
test. The mean of acquisition in passive avoidance 
test showed a non-significant decrease in sham 
group compared to control group. This result
exhibited significantly decreased acquisition to 
passive avoidance response in AD group compared 
to control and sham group (P<0.0001, Fig. 2).
  Histological procedure. Two types of plaque were 
seen in AD cerebral cortices, diffuse plaques and 
compacted amyloid cores. In this study by 
Bielschowsky silver staining, diffuse plaques were 
detected in the cerebral cortex and hippocampus
(Fig. 3). These diffuse cerebral plaques ranged in 
size smaller than 210 µm. In this study, the number 
of plaques in hippocampus was more than cortex 
and white matter. Also, neuronal population 
reduction in hippocampus was observed comparing
to cortex. The perivascular amyloid deposits were 
seen clearly in cortex, hippocampus and white 
matter. Dystrophic neurites were not seen associated 
with diffuse plaques. Diffuse plaques were not found 
with reactive neurites or glial cells. Compacted 
amyloid cores were present in the cerebral cortex, 
hippocampus and white matter. scattered amyloid 
cores were seen by Congo red and Bielschowsky 
silver stain in AD cortex and hippocampus. Rare 
amyloid angiopathy was detected in the cerebrum, 
hippocampus and white matter in AD group (Fig. 3). 
Congo red staining showed evidence of some 
birefringent material indicating the presence of 
fibrillar structures. Congo red staining slides showed 
typical green birefringence under polarized light in
AD group (Fig. 4). Nissl-stained neuronal densities 
indicated AD group (Fig. 5) had consistent reduction 
of neuron densities 55.6% in the CA1 and 25.9% in 
cortex. The number of plaques in the hippocampus
were present 11 ± 2 diffuse plaques and 3 ± 1 cored 
plaques per 100× field and the neuritic plaques in 
cerebral cortex showed numerous 7 ± 2 diffuse
plaques and 2 ± 1 cored plaques per 100× field
(Table 1).
TUNEL procedure. TUNEL staining was used 
to show apoptosis (Fig. 6). Brain tissue sections 
from AD   cases   showed   comprehensive cellular
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Fig. 3. Modified Bielschowsky staining. AD group: cerebral cortex (A, B, and J), hippocampus (C, D and H), white mater (E) and 
blood vessels (F and G). (A) cerebral diffuse plaques in the cortex (40×); (B) compacted amyloid cores plaques in the cortex (40×); 
(C1) compact plaques in CA1 region in Hippocampus (40×); (C2) diffuse plaques in CA1 region in Hippocampus; (D1) compact 
plaques in Hippocampus parenchyma (40×); (D2) neurofibrillary tangles in CA1; (E1) compact plaques in white mater (40×); (E2) 
amyloid deposits in blood vessels (40×); (F1) and (F2) blood vessels Bielschowsky staining (40×); (G) amyloid angiopathy in arteriole
(100×); (H1) compact plaques in white mater (40×); (H2) amyloid deposits in blood vessels; (J) cortex in control group (40×).
DNA fragmentation revealed by TUNEL. This 
method detected primarily double-stranded DNA 
breaks via TdT. In AD group in CA1 region of 
hippocampus and cortex, TUNEL-positive cells 
were observed.
DISCUSSION
  In this study, we demonstrated diffuse plaques and 
compacted amyloid cores by modified Bielschowsky 
silver staining in the cerebral cortex and 
hippocampus. Also, we showed the increased
number of plaques and decreased neuronal
population in hippocampus compared to cortex and 
white matter by modified Congo red staining that 
showed typical green birefringence under polarized
light in AD group. For evaluation of behavioral 
changes in small animals such as rats and mice, the
following methods have been used: (1) passive
avoidance response, (2) active avoidance response,
and (3) the maze test [9]. In this study, passive
avoidance response and maze test were used to
appraise the preservation of memory after Aβ
effects. The AD groups that received Aβ, showed
Table 1. Neuronal counts in cerebral cortex and CA1.
Group Region Neurons per mm2 Average of neurons per field Std. deviation
AD
CA1 2.920* 76.0 1.491
Cortex 0.294* 275.0 7.454
control
CA1 6.350** 165.0 3.830
Cortex 0.397** 374.1 2.066
Sham
CA1 6.250 162.6 0.843
Cortex 0.392 366.5 1.509
*P<0.0001, AD group compared with control and sham groups; **P>0.05, control group compared with sham group.
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Fig. 4. Tissue obtained with Congo red staining from AD group (40×). (A) amyloid deposits in CA1 region; (B) typical green 
birefringence amyloid deposits under polarized light and (C) control group (40×).
significant    decrease     in     behavior     scores  in
comparison with the control and sham group in Y-
maze test and passive avoidance response. This 
study similar to other studies in this field confirmed 
that deposition of Aβ in AD brains impairs learning
and  memory  [1, 8, 12].   The    passive  avoidance 
procedure is a quick and simple task to administer
[23]. Therefore, this procedure is widely used to
measure cognitive alterations after drug
administration, lesions, and behavioral mani-
pulations [24]. The passive avoidance test has been
widely used to evaluate rodent working memory 
ability in association with cortical and hippocampal 
functions [25]. In this study, the latency periods of
passive avoidance response were evaluated in these 
rats and the retention of memory was significantly
disturbed in AD group. The neurotransmitters in the 
central nervous system have important roles in 
normal functioning and behavior of the adult 
individual. They interact with each other in complex
networks in the process of learning and memory, in 
which acetylcholine is proposed to have a central 
Fig. 5. Nissl staining AD group. (A) CA1 Nissl staining AD 
group (40×): (1) cell death and (2) apoptotic body; (B) control 
group (40×). 
Fig. 6. Cell death detection in situ by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL). Cells with 
positive TUNEL staining (brown) and exhibiting apoptotic morphology were considered apoptotic. (A1) AD group Tunel positive in 
cortex; (A2) apoptosis; (B) control group Tunel negative in cortex; (C1) AD group Tunel positive in CA1; (C2) apoptosis; (D) control 
group Tunel negative in CA1 (40×).
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role. Acetylcholinestrase is an enzyme responsible 
for hydrolyzing and so deactivating acetylcholine in
the body. Alterations in this enzyme level are 
indicative of impairment of cholinergic function 
[26]. Several studies have reported that infusing Aβ 
peptide (1-40) into the rat cerebral ventricle induces 
learning impairment, neuronal and morphological 
degeneration and alteration of enzyme markers such 
as acetylcholine esterase and choline acyltransferase; 
all of which are well-known characteristics of AD 
[27]. The hippocampus and the cerebral cortex are 
the key structures of memory formation; Aβ 
injection into hippocampus can deficit in both 
synaptic transmission and plasticity [28, 29, 30] and 
neuronal dysfunction [31]. 
In the present study, cerebral plaques of the diffuse 
type were present only in AD group. The cerebral 
lesions observed in cases of AD are definable as 
diffuse plaques because they appear to lack 
dystrophic neurites and that is dispersed rather than 
compacted into a core. An alternative view could be 
that diffuse plaques are a separate plaque type which 
does not evolve further in the cerebral cortex. We 
did not detect morphologic changes in any of the 
cells or processes in areas of cortex containing 
abundant diffuse plaques. Injection of Aβ protein is 
widely used in AD model preparation. Aβ 
proteinosis is an important structure of senile 
plaques and is thought to be the main reason for the 
loss of neurons and the resulting memory disability 
[32]. 
In present survey in the AD group, it was shown 
that Aβ to be caused DNA damage in neurons that 
finally degenerate and die. Apoptotic and necrotic 
changes that make neuronal cell death occur in AD 
brains. Multiple laboratories have reported evidence 
for apoptosis, or programmed cell death, in
pathological tissues obtained from the brains of AD
patients [33]. Although TUNEL is not a definitive 
marker of apoptosis, it still allows identification of 
dying cells in situ [32, 33]. Lassmann et al. [34] also 
reported that TUNEL-positive cells were positioned 
in brain regions containing extracellular Aβ 
deposition. In this regard, although there has been 
some debate on whether amyloid deposition 
correlates with the degree of dementia [35], recent 
evidence indicates that the severity of dementia can 
be correlated with the Aβ load [36]. This does not, 
however, imply that other factors such as 
cytoskeletal abnormalities are not also involved in 
the disease process [37]. 
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